LINCOLN PHARMACEUTICALS
Back to Balance Sheet
|
LINCOLN PHARMACEUTICALS Last 5 Year Sundry Debtors History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Sundry Debtors | ₹162 Cr | ₹136 Cr | ₹116 Cr | ₹113 Cr | ₹101 Cr |
What is the latest Sundry Debtors ratio of LINCOLN PHARMACEUTICALS ?
Year | Sundry Debtors |
---|---|
Mar2024 | ₹162 Cr |
Mar2023 | ₹136 Cr |
Mar2022 | ₹116 Cr |
Mar2021 | ₹113 Cr |
Mar2020 | ₹101 Cr |
How is Sundry Debtors of LINCOLN PHARMACEUTICALS Trending?
Years | Sundry Debtors | % Change | |
---|---|---|---|
Mar2024 | ₹162 Cr | 18.66 | |
Mar2023 | ₹136 Cr | 17.59 | |
Mar2022 | ₹116 Cr | 2.29 | |
Mar2021 | ₹113 Cr | 11.85 | |
Mar2020 | ₹101 Cr | - |
Compare Sundry Debtors of peers of LINCOLN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LINCOLN PHARMACEUTICALS | ₹1,320.3 Cr | -3.4% | -14.8% | 33.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹453,486.0 Cr | -0.6% | 1.3% | 65.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,321.0 Cr | -1.1% | 11.4% | 64% | Stock Analytics | |
CIPLA | ₹125,852.0 Cr | -2.3% | -6.8% | 33.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹111,799.0 Cr | 1.5% | 1% | 22.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹102,726.0 Cr | -4.2% | -8.1% | 72.3% | Stock Analytics |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LINCOLN PHARMACEUTICALS | -3.4% |
-14.8% |
33.3% |
SENSEX | -0.7% |
-2.4% |
22% |
You may also like the below Video Courses